The multi-billion dollar health and beauty industry continues to experience strong growth. In 2017, the global cosmetic products market alone was valued at around 532 billion USD and is expected to grow to around 863 billion USD in 2024, according to a Zion Market Research report.
It’s no surprise then, why strategic acquirers and private equity firms are keeping a close eye on the industry. Investors are actively seeking opportunities which can help to reach their strategic and financial goals.
In our Health & Beauty Active Acquirer Report, we explore recent acquirer trends, strategic insights (including key investment drivers), and transaction information to help you stay ahead in this dynamic and constantly evolving industry.
Are you interested in finding out about the strategic acquisition focus of the world’s largest consumer product manufacturers? Discover more about the companies driving the health and beauty sector, and what is driving their acquisition activity.
Click below to download the full report
Objective Capital Partners has decades of experience and our tenacious advocacy for our clients has allowed us to create and maintain relationships with active acquirers and investors in our industries of focus. Whether preparing for sale or strategizing for future exit options, knowing the active acquirers and investors within your industry niche is an important factor to achieving your transaction goals.
If you are interested in learning more about the trends and insights in the health and beauty industry, or would like to discuss your own acquisition goals contact us at (858) 208-3442 or [email protected].
References:
—
Disclosure
Objective Capital Partners is a leading investment banking advisory firm whose Principals have collectively engaged in more than 500 successful transactions serving the transaction needs of growth stage and mid-size companies. The executive team has a unique combination of investment banking, private equity, and business ownership experience that enables Objective Capital Partners to provide large enterprise caliber investment banking services to companies with annual revenues up to $250MM. Services include sale transactions, partnering/ licensing, equity and debt capital raises, valuation and comprehensive advisory services. The firm uses a proprietary process to work to achieve maximum company valuation, premium pricing, and high client satisfaction rates post-sale. The firm’s industry expertise is focused on 5 verticals including healthcare, life sciences, business services, technology, and consumer products. Additional information on Objective Capital Partners is available at www.objectiveibv.com.
This article is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.
